Text-Only | Login

Navigation: Home

Navigation: About

Navigation: Topics

Navigation: Projects

Navigation: Membership

Navigation: Boards

Navigation: Events

Navigation: Reports


Search.
Return to top.




Return to top.


Contact Information.


Institute of Medicine
500 Fifth Street NW
Washington DC 20001
iomwww@nas.edu
tel: 202.334.2352
fax: 202.334.1412

Media Contact
(Journalists Only)

news@nas.edu
tel. 202.334.2138
fax: 202.334.2158

Staff Directory


Return to top.

Institute of Medicine.


Immunization Safety Review


More Information Print   Email

The Immunization Safety Review Committee (ISR) was a project within the Institute of Medicine that addressed current and emerging vaccine-safety concerns. The committee provided independent, non-biased advice to vaccine policy-makers, as well as practitioners and the public.

Meetings
The committee met three times a year from 2001 - 2004. The topic of each meeting was a specific vaccine-safety question. For each vaccine-safety question, the committee read and discussed the relevant epidemiologic evidence for or against a causal relationship, as well as any case reports, and clinical evidence. The committee also heard presentations from the authors of key papers, as well as ongoing, unpublished research.  Presentations for each meeting are available by clicking on the meetings listed at the bottom of this page.

Reports
Committee reports, as well as their summaries and press releases, are available (scroll to bottom of the page) online in full-text format. Following each meeting, the committee wrote a report with three types of conclusions about:

  • the causal relationship between the vaccine and adverse effect,
  • the biologic mechanisms that could account for the adverse effect, and
  • the significance of the safety concern in the context of society at large (e.g., the seriousness, treatment, complications of the wild-type disease and hypothesized adverse effects of the vaccine).

Based on their conclusions, the committee made recommendations for future activities (i.e. surveillance, research, policy, communication) regarding the safety concern. The committee's reports are addressed to federal vaccine research policymakers, state and local vaccine program implementers, health care professionals, the public, and the media.
 

Free Executive Summaries
Executive summaries of each of the committee's eight report are available for free in PDF format.

Who We Are
The ISR committee was composed of 14 people with expertise in:

  • Medicine (pediatrics, nursing, infectious disease, internal medicine)
  • Public Health (epidemiology, biostatistics, health communication)
  • Medical and Scientific Research (immunology, genetics, neurology)
  • Risk Perception, Decision Analysis, Ethics

The committee was sponsored by the Centers for Disease Control and Prevention, and the National Institutes of Health.
 

 



Project Meetings
Immunization Safety Review: Vaccines and Autism Feb 9, 2004
Immunization Safety Review Committee Meeting: Influenza Vaccine and Neurological Complications Mar 13, 2003
Immunization Safety Review Committee Meeting: Vaccinations and Sudden Unexpected Death in Infancy Oct 28, 2002
Immunization Safety Review Committee Meeting: Simian Virus-40 Contamination of Polio Vaccine and Cancer Jul 11, 2002
Immunization Safety Review Committee Meeting: Simian Virus-40 Contamination of Polio Vaccine and Cancer Jul 11, 2002
Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders Mar 11, 2002
Immunization Safety Review Committee Meeting: Multiple Immunization and Immune Dysfunction Nov 12, 2001
Immunization Safety Review Committee Meeting: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders Jul 16, 2001
Immunization Safety Review Committee Meeting: MMR Vaccine and Autism Mar 8, 2001
Immunization Safety Review Committee Organizational First Meeting Jan 11, 2001
Related Reports
Immunization Safety Review: Vaccines and Autism Immunization Safety Review: Vaccines and Autism
May 17, 2004
Immunization Safety Review: Influenza Vaccines and Neurological Complications Immunization Safety Review: Influenza Vaccines and Neurological Complications
Oct 6, 2003
Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy
Mar 12, 2003
Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer
Oct 22, 2002
Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders
May 30, 2002
Immunization Safety Review: Multiple Immunizations and Immune Dysfunction Immunization Safety Review: Multiple Immunizations and Immune Dysfunction
Feb 20, 2002
Immunization Safety Review: Thimerosal - Containing Vaccines and Neurodevelopmental Disorders Immunization Safety Review: Thimerosal - Containing Vaccines and Neurodevelopmental Disorders
Oct 1, 2001
Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism
Apr 23, 2001



Last Updated: 4/10/2008, 11:55 AM RSS








Home | About | Topics | Projects| Memberships| Boards | Events | Reports | Sitemap
The logo of the National Acadamies. This link goes to www.nationalacademies.org.
Return to top.

Copyright © 2008 National Academy of Sciences. All rights reserved.

Terms of Use and Privacy Statement